Praxis precision medicines to present data from prax-944 for essential tremor at 2022 american academy of neurology annual meeting

Boston, april 01, 2022 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that data from its prax-944 essential tremor (et) program will be presented at the upcoming 2022 american academy of neurology (aan) annual meeting, which will take place in seattle, washington from april 2 – 7, 2022 and virtually from april 24 – 26, 2022. abstracts can be accessed on the aan meeting website.
PRAX Ratings Summary
PRAX Quant Ranking